Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học 'Respiratory Research cung cấp cho các bạn kiến thức về ngành y đề tài: "The incidence of multidrug and full class resistance in HIV-1 infected patients is decreasing over time (2001–2006) in Portugal. | Retrovirology BioMed Central Research The incidence of multidrug and full class resistance in HIV-1 infected patients is decreasing over time 2001-2006 in Portugal Jurgen Vercauteren 1 Koen Deforche1 Kristof Theys1 Michiel Debruyne2 Luis Miguel Duque3 Susana Peres4 Ana Patricia Carvalho4 Kamal Mansinho4 Anne-Mieke Vandamme1 and Ricardo Camacho4 5 Address 1Rega Institute Katholieke Universiteit Leuven Leuven Belgium 2UCS. Dept. of Mathematics Katholieke Universiteit Leuven Heverlee Belgium 3Hospital de S. Bernardo Sétubal Portugal 4Centro Hospitalar de Lisboa Occidental Lisbon Portugal and 5Universidade Nova de Lisboa Lisbon Portugal Email Jurgen Vercauteren - jurgen.vercauteren@uz.kuleuven.ac.be Koen Deforche - koen.deforche@uz.kuleuven.ac.be Kristof Theys - kristof.theys@uz.kuleuven.ac.be Michiel Debruyne - Michiel.Debruyne@ua.ac.be Luis Miguel Duque - luismiguelduque@gmail.com Susana Peres - susana.reisperes@sapo.pt Ana Patricia Carvalho - pkarvalho@iol.pt Kamal Mansinho - udip@hegasmoniz.min-saude.pt Anne-Mieke Vandamme - annemie.vandamme@uz.kuleuven.be Ricardo Camacho - ricardojcamacho@sapo.pt Corresponding author Open Access Published I February 2008 Received I November 2007 Accepted 1 February 2008 Retrovirology 2008 5 12 doi 10.1186 1 742-4690-5-12 This article is available from http www.retrovirology.cOm content 5 1 12 2008 Vercauteren et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http creativecommons.org licenses by 2.0 which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Despite improvements in HIV treatment the prevalence of multidrug resistance and full class resistance is still reported to be increasing. However to investigate whether current treatment strategies are still selecting for multidrug and full .